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http://www.biomedcentral.com/1752-0509/7/19RESEARCH ARTICLE Open AccessMapping global effects of the anti-sigma factor
MucA in Pseudomonas fluorescens SBW25 through
genome-scale metabolic modeling
Sven EF Borgos1,2†, Sergio Bordel3†, Håvard Sletta2, Helga Ertesvåg1, Øyvind Jakobsen2, Per Bruheim1,
Trond E Ellingsen2, Jens Nielsen3 and Svein Valla1*Abstract
Background: Alginate is an industrially important polysaccharide, currently produced commercially by harvesting of
marine brown sea-weeds. The polymer is also synthesized as an exo-polysaccharide by bacteria belonging to the
genera Pseudomonas and Azotobacter, and these organisms may represent an alternative alginate source in the
future. The current work describes an attempt to rationally develop a biological system tuned for very high levels of
alginate production, based on a fundamental understanding of the system through metabolic modeling supported
by transcriptomics studies and carefully controlled fermentations.
Results: Alginate biosynthesis in Pseudomonas fluorescens was studied in a genomics perspective, using an alginate
over-producing strain carrying a mutation in the anti-sigma factor gene mucA. Cells were cultivated in chemostats
under nitrogen limitation on fructose or glycerol as carbon sources, and cell mass, growth rate, sugar uptake,
alginate and CO2 production were monitored. In addition a genome scale metabolic model was constructed and
samples were collected for transcriptome analyses. The analyses show that polymer production operates in a close
to optimal way with respect to stoichiometric utilization of the carbon source and that the cells increase the uptake
of carbon source to compensate for the additional needs following from alginate synthesis. The transcriptome
studies show that in the presence of the mucA mutation, the alg operon is upregulated together with genes
involved in energy generation, genes on both sides of the succinate node of the TCA cycle and genes encoding
ribosomal and other translation-related proteins. Strains expressing a functional MucA protein (no alginate
production) synthesize cellular biomass in an inefficient way, apparently due to a cycle that involves oxidation of
NADPH without ATP production. The results of this study indicate that the most efficient way of using a mucA
mutant as a cell factory for alginate production would be to use non-growing conditions and nitrogen deprivation.
Conclusions: The insights gained in this study should be very useful for a future efficient production of microbial
alginates.
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Pseudomonas is a genus of Gram-negative bacteria with
features that have made them interesting to a wide com-
munity of researchers for a long time. Pseudomonas spp.
range from important human pathogens (P. aeruginosa),
via biocontrol agents and plant commensals useful in
agriculture (P. fluorescens) to one of the most widely
used “cell factories” for production of high-value-added
products in industrial biotechnology (P. putida), and the
genus is characterized by a great metabolic versatility.
Several species of Pseudomonas are also notable and
well-studied in their capability to form biofilms [1], aggre-
gates of cells that adhere to each other and to surfaces,
embedded in an extracellular polymeric matrix. Formation
of such biofilms can have serious clinical consequences, as
seen in infections by the opportunistic human pathogen
P. aeruginosa. Patients that are immunocompromised, in-
cluding the general aging population, are susceptible to
this pathogen both topically and systemically, and among
cystic fibrosis patients, lung infections by P. aeruginosa
are prevalent and have a major impact on morbidity and
mortality [2,3].
One striking feature that is present in the majority of P.
aeruginosa infections of the CF lung, is the so-called mu-
coid conversion of the pathogen, yielding a phenotype that
produces large amounts of the exopolysaccharide alginate.
This phenotype correlates with the ability of P. aeruginosa
to persist in the lungs of CF patients [4] and is a general
marker of poor survival for these patients [5]. The mucoid
conversion typically takes place through inactivating mu-
tations arising in the regulatory gene mucA [6], or proteo-
lytic degradation of the encoded MucA protein [7]. MucA
acts as an anti-sigma factor, binding and sequestering the
alternative sigma factor σ22, encoded by the algU gene,
that is essential for alginate production [8]. σ22 sigma
factors are members of the ECF (extra cytoplasmic func-
tion) family of transcription factors that are known to re-
spond to membrane stresses, and a recent microarray
analysis [9] found that AlgU is a global stress response
sigma factor, inducing several systems apart from alginate
biosynthesis. This study also identified gene subsets encod-
ing virulence factors specifically induced on conversion to
mucoidy, including HCN biosynthesis. The metabolic fea-
tures controlled by the AlgU-MucA system are not well
studied, but a very recent metabolic footprinting study con-
cluded that MucA modulates osmotic stress tolerance [10].
Alginate is a linear copolymer of mannuronic acid and
its C-5 epimer guluronic acid, and bacterial alginate is
only known to be produced by two genera, Pseudomonas
and Azotobacter. An important industrial polymer, algin-
ate is produced in bulk from seaweeds, but bacterial algi-
nates have attracted significant interest over the last
years due to the presence of alginate modifying enzymes,
i.e. epimerases [11], in the producing organisms. Theseenzymes, taken together with the possibility to produce
very homogeneous alginate from liquid bacterial cultiva-
tions, allow precise manipulation of the relative content
and sequence of mannuronic and guluronic acid residues
in the alginate, which influences the physico-chemical and
immunological properties of the purified polymer signifi-
cantly [12]. The genes encoding the alginate biosynthetic
machinery are highly similar in the producing species, and
are in Pseudomonas spp. organized in a 12-gene operon
(algD–8–44–K–E–G–X–L–I–J–F–A) under the algD pro-
moter – the only exception being the algC gene, encoding
a phosphomannomutase, that is localized outside of the
operon and transcribed from its own promoter. The algin-
ate biosynthetic pathway (for reviews, see e.g. [13,14])
originates from fructose-6-phosphate and proceeds via the
activated monomer GDP-mannuronic acid, to concomi-
tant polymerization and export to the extracellular space.
During the polymerization/export, mannuronic acid resi-
dues can be epimerized to guluronic acid, and can be
O-acetylated in the O-2 and/or the O-3 position. One
molecule of GTP and two molecules of NAD+ are con-
sumed per monomer unit incorporated (counting from
fructose-6-phosphate), whereas the degree of acetyl group
incorporation depends strongly on the producing species
[15]. P. fluorescens SBW25 is an organism well suited for
industrial production of alginate as compared to either P.
aeruginosa or A. vinelandii, because of both its non-
pathogenicity and the relative simplicity of cultivation on
an industrial scale.
Genome-scale metabolic reconstruction has become a
well-established method for analysis of microbial metab-
olism, with numerous applications [16,17]. Although not
directed towards dynamic modeling by nature, the
steady-state assumption that underlies a stoichiometric
metabolic reconstruction is well approximated in con-
tinuous liquid culture. Based on the annotated genome,
the full spectrum of available metabolic pathways in the
organism is reconstructed, and coupled with isotope la-
beling experiments, the actual flux distribution between
these pathways can be assessed [18]. Alternatively, global
data sets, most commonly transcriptomics data, can be
used to identify highly regulated parts of the metabolic
network [19], even if the metabolic reconstruction does
not contain representations of regulatory mechanisms
per se. This, in combination with computer simulations
of gene knock-outs or knock-ins in the stoichiometric
model, can identify attractive targets for metabolic en-
gineering in the organism [20].
In this study, we have investigated the plant commensal
P. fluorescens SBW25 by genome-scale modeling
complemented by chemostat cultivations and microarray
analysis of gene expression. The recently published gen-
ome sequence of SBW25 [21] (accession number [EMBL:
AM181176]) shows that it contains all genes necessary for
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demonstrated the potential for high levels of alginate pro-
duction in P. fluorescens [22]. Through genome-scale
metabolic modeling, we aim to identify genetic and meta-
bolic features that are crucial for alginate biosynthesis.
The close coupling of alginate biosynthesis to central car-
bon metabolism necessitates a systems biology approach,
and the results gained from the investigation of this non-
pathogenic alginate producer could help to identify both
novel antimicrobial targets for human medicine and key
pathways features for optimized production of an industri-
ally important biopolymer. Furthermore, we could by
using the genome-scale model for performing integrative
analysis identify the global role of the anti-sigma factor
MucA on metabolism. The P. fluorescens metabolic recon-
struction complements existing models of P. aeruginosa
[23] and P. putida [24,25] and allowed us to perform a
comparative metabolic analyses of these three important
pseudomonads.
Results and discussion
Strain constructions
P. fluorescens wild-type strains have not been found to
produce alginate under laboratory conditions, whereas it
is known that mucA deficient strains of P. aeruginosa do
(see e.g. [26]). An SBW25 mucA strain was constructed
by introducing a point mutation leading to a truncated
version of MucA in which the 37 C-terminal amino
acids are absent. The algC gene is the only one located
outside the alg operon that encodes an alginate biosyn-
thetic enzyme. Whereas expression of the alg operon
genes is known to be regulated by MucA, this is not the
case for algC in P. fluorescens (unpublished results).
As the absence of a functional MucA protein in the
cell is expected to have pleiotropic effects beyond algin-
ate biosynthesis [9], it was necessary to construct control
strains in order to discern between effects caused by al-
ginate production, by over-producing the alginate bio-
synthetic enzymes, and by the more general pleiotropic
effects of a defective anti-sigma factor MucA. In addition
to the wild-type and the alginate-producing mucA strain,
three control strains were constructed as described in
Additional file 1. Relevant phenotypical features of the
strains used in this study are summarized in Table 1.
Firstly, the in-frame deletion inactivation of algC, i.e. aTable 1 Overview of alginate-related phenotypes in the strain
Strain mucA algC
Wild-type + +
ΔalgC + -
mucA - +
mucA ΔalgC - -
mucA TTalgD - +ΔalgC strain, encoding wild-type MucA would allow us
to observe potential roles of AlgC outside the alginate
biosynthetic pathway, including consequences of poten-
tial effects on LPS [27] and rhamnolipid [28] biosyn-
thesis. Secondly, a mucA ΔalgC strain would not
produce alginate, but would show pleiotropic effects fol-
lowing from mucA inactivation and, importantly, the cel-
lular effect of overproducing the remaining alginate
biosynthetic proteins. Finally, strain mucA TTalgD was
constructed that does not produce alginate, as a tran-
scription terminator (TT) is inserted between PalgD and
the translation start of algD. This strain should still ex-
hibit the pleiotropic effects of mucA inactivation, al-
though with minimal alginate-related effects as neither
alginate nor the alginate biosynthetic proteins (except
AlgC) should be produced. It needs mentioning, how-
ever, that very recently, Paletta and Ohman [29] found
two putative promoters internal to the alg operon in P.
aeruginosa, upstream of the alginate epimerse gene algG
and the alginate acetylation gene algI, respectively. This
could indicate the possibility of differential regulation
within the operon to alter polymer structure under vary-
ing conditions.
Chemostat cultivations
Chemostat cultivation, allowing precise control of the
cellular specific growth rate μ, ensures maximal homo-
geneity of the sampled cellular population both in the
spatial and temporal dimensions (steady-state condi-
tions) provided genetic stability.
A preliminary screening of carbon sources in P.
fluorescens fermentations indicated that fructose and gly-
cerol supported a significantly higher alginate yield per
mmolC than did either glucose, sucrose, galactose, lactose
or lactate. As both the uptake mechanism and point of
entry into metabolism is different for fructose and glycerol,
both carbon sources were selected for cultivations. Fructose
is imported by the fructose-specific PTS FruAB-system
[30], yielding fructose-1-phosphate, whereas glycerol is
taken up by GlpF-facilitated diffusion and concomitant
phosphorylation to glycerol-3-phosphate upon cytoplasmic
entry [31]. For biosynthesis of alginate, fructose-1,6-
bisphosphate is then the common precursor from both
fructose and glycerol, from fructose by direct phosphoryl-
ation of fructose-1-phosphate, and from glycerol-3-s used in this study
alg operon proteins produced Alginate production
- -
- -
+ +
+ -
- -
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then generated from fructose-1,6-bisphosphate by fruc-
tose bisphosphatase, and is the immediate substrate for
the alginate biosynthetic enzymes by first converting
fructose-6-phosphate to mannose-6-phosphate. Note that
similarly to other pseudomonads, SBW25 does not
contain a phosphofructokinase, thus lacking the possibil-
ity to phosphorylate fructose-6-phosphate.
In addition to the SBW25 wild-type (WT) strain, two
genetically engineered strains were grown on both car-
bon sources in order to elucidate the impact of alginate
biosynthesis on cellular metabolism. As described above,
the mucA strain has the full mucoid phenotype, whereas
the mucA TTalgD strain has a second mutation that
abolishes expression of the alg operon biosynthetic
genes. In the fructose cultivations, the two additional
control strains ΔalgC and mucA ΔalgC were included to
better understand the effects of MucA outside alginate
biosynthesis as discussed above.
Chemostat cultivations were performed as described in
Materials and Methods, with fructose or glycerol as the
sole carbon source (both 40 g/l), under nitrogen limita-
tion of growth. Measured variables were biomass con-
centration, residual carbon source in the medium,
alginate production and CO2 evolution (respiration). In
a chemostat, specific growth rate is fixed and based on
this, specific rates of carbon source uptake, carbon diox-
ide production and alginate production were calculated,
and the data are summarized in Table 2. Carbon balance
calculation, as listed in the rightmost column, shows that
all carbon taken up can be accounted for to within 95%
in all conditions tested.
Bacterial alginates are O-acetylated to varying degrees
[15]. The degree of acetylation was determined by HPLC
measurements of acetate released from the alginate by
hydrolysis to be 0.19 and 0.32 on fructose and glycerol,Table 2 Physiological characteristics of the strains and condit
Carbon source Strain OD660 C source Uptake
[mmolC/ gDW h]
Alginate produc
deacetylated
[mmolC/gDW h
Fructose Wild-type 7,8 9,4 -
Fructose mucA 7,0 18,3 12,3
Fructose ΔalgC 8,1 9,1 -
Fructose mucA ΔalgC 8,4 5,8 -
Fructose mucA TTalgD 9,2 5,6 -
Glycerol SBW25 9,2 8,3 -
Glycerol mucA 7,4 17,5 10,6
Glycerol mucA TTalgD 9,9 6,9 -
Measured and calculated physiological parameters for chemostat cultivations (D = 0
for mmolC/gDW h in biomass is calculated from the specific growth rate used in th
assumed in the genome scale model. The % value for carbon balance represents th
of the carbon taken up by the cells.respectively. No free acetate was detected in the culture
growth media.
It is apparent from Table 2 that the mucA inactivation
has a profound effect on respiration in P. fluorescens
SWB25. Whereas the measured differences between the
WT strain and the ΔalgC mutant on fructose are negli-
gible, the mucA ΔalgC mutant, which also does not pro-
duce alginate, has a significantly lower respiration, and
hence a lower fructose uptake. This is even more pro-
nounced in the mucA TTalgD strain, which makes nei-
ther alginate nor the dedicated alginate biosynthetic
proteins. In the mucA strain, respiration is still low,
whereas the fructose uptake is strongly elevated to ac-
commodate the carbon drain into alginate. On glycerol,
the reduction in respiration going from the WT strain to
the mucA mutant reflects the case on fructose, whereas
the mucA TTalgD strain on glycerol has a level of respir-
ation that is intermediate to those of the WT and mucA
strains, as opposed to the fructose case. This is an early
indication that metabolism of the two carbon sources is
regulated differently in P. fluorescens SBW25.
Transcriptome analyses
Based on the annotated P. fluorescens SBW25 genome se-
quence, a custom expression microarray was constructed
for transcriptome analysis. This array covers 6,519 genes,
including 478 genes from the environmental plasmid
pQBR103. The apparent discrepancy with the 6,009
chromosomal genes published by Silby et al. [21] is due to
the inclusion of some putative pseudogenes in the micro-
array. Note that the pQBR103 plasmid included in the
published genome sequence was shown to be acquired by
the organism during a field release experiment [32], and is
not present in the originally isolated SBW25 strain used in
this study; it was included in the microarray design for
versatility in potentially comparative studies.ions studied
tion,
]
Acetate (acetyl
from alginate)
[mmolC/gDW h]
CO2 excretion
[mmolC/
gDW h]
C in biomass
[mmolC/
gDW h]
C balance [%]
- 7,5 1,51 95,7
0,77 4,6 1,51 104,4
- 7,4 1,51 97,6
- 4,3 1,51 99,3
- 3,9 1,51 96,9
- 6,4 1,51 96,3
1,22 3,6 1,51 96,8
- 5,0 1,51 95,4
.04) of P. fluorescens SBW25 (wild-type) and derived mutant strains. The value
e experiments (μ = 0.04 hr-1) and the biomass stoichiometric composition
e sum of carbon accounted for in alginate, CO2 and biomass as a percentage
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pendent chemostat cultivations as described above.
The complete transcriptome data set is available in
Additional file 2, both as raw and quantile normalized
data. Process variability in RNA isolation, prepara-
tion and analysis was investigated (data not shown),
confirming that the majority of the observed variability
between replicates does indeed represent biological dif-
ferences between cultivations. Principal component ana-
lysis (PCA) was performed on the transcriptome data
described here, and the results are shown in Figure 1. It
confirms that there is good reproducibility within-80
-60
-40
-20
0
20
40
60
80
-600 -400 -200 0 200
-200
-150
-100
-50
0
50
100
150
-1000 -500 0 500 1000
PC2
PC2a
c
Figure 1 PCA plots of microarray data from chemostat cultivations. P
component 1, x axis, 85.1% explained variation) vs. PC2 (y axis, 9.3% explain
(x axis, 5.5% explained variation) vs. PC2 (y axis, 9.3% explained variation). P
PCs. Panel 1c): All datapoints from fructose-grown cultivations, PC1 (90.1%
source fructose; triangles, carbon source glycerol. Strains: Grey, WT; yellow,
datapoints are independent fermentations, i.e. all biological conditions are
are selected by ANOVA with p-values < 0.005.replicate sample sets. There is a clear PCA separation of
the strains into three distinct groups, along the two first
principal components. (Figure 1a,c). The mucA and
mucA ΔalgC strains grown on fructose are separated
from each other, and from the remaining three strains
which cluster closely together. The mucA ΔalgC is
phenotypically distinct in that it does not produce algin-
ate, but the alginate biosynthesis genes are transcribed
and translated. The anti-sigma factor MucA is effectively
a global regulator through the MucA–AlgU system, and
a strong effect on cellular processes can be expected.
Interestingly, the mucA TTalgD strain, which does not400 600 800 1000
1500
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PC1 PC3
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PC2b
anel 1a): All strain–carbon source datapoints, PC1 (principal
ed variation). Panel 1b): All strain–carbon source datapoints, PC3
anel 1a and 1b will combine to show all three dimension in three first
explained variation) vs. PC2 (7.4% explained variation). Squares, carbon
ΔalgC; red, mucA; blue, mucA ΔalgC; green, mucA TTalgD. All
present in triplicate data points. Genes used to construct the PCA
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Figure 2 Differential gene expression profiles in carbon source
regulated operon. Gene expression profiles (log2 normalized
expression values) in all strain–carbon source combinations for gene
PFLU3201, which is the first gene in the putative operon PFLU3201–
PFLU3193. Dark grey, fructose as carbon source; light grey, glycerol
as carbon source. Data points are averages of three independent
cultivations; error bars equals one standard deviation.
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enzymes, does not group with either the mucA or the
mucA ΔalgC strains, but rather with the WT. This could
indicate that even the expression of only the alginate
biosynthetic enzymes with no concomitant alginate bio-
synthesis (as is the case in the mucA ΔalgC strain) im-
parts a significant physiological load on the cells. This is
supported by the observation that when genes are clus-
tered according to their expression pattern across all
strains (data not shown), virtually all genes encoding
ribosomal proteins show an expression profile similar to
that of the alg operon (i.e. high relative expression in the
mucA and mucA ΔalgC strains). It should also be noted
that in the PCA plots, the mucA strain on glycerol is
clustered with the mucA ΔalgC strain, rather than the
mucA strain, on fructose (Figure 1a), although a separ-
ation between carbon sources can be observed along
PC3 (Figure 1b). This somewhat counterintuitive cluster-
ing could be an indication that the mucA inactivation
has different physiological effects depending on the car-
bon source utilized by the cells.
If only the subset of metabolic genes is considered and
all mutant strains on fructose are compared against the
WT, the indicative differences observed in the PCA plot
are confirmed. Using 2-fold regulation and ANOVA
p-value of < 0.005 as significance cut-off, no metabolic
genes are changed in the ΔalgC mutant, whereas in the
mucA TTalgD strain, only algC and the PFLU5987 gene
are regulated above the significance cut-off, both up in the
mutant strain. The latter gene encodes an acetylglutamate
kinase ArgB (EC 2.7.2.9). However, this gene is localized
immediately downstream of algC on the chromosome,
and they are most likely co-transcribed.
In the mucA strain, and to some extent in the mucA
ΔalgC strain, two functional sets of genes besides the al-
ginate biosynthetic operon are recognized as significantly
upregulated, in addition to the genes encoding ribosomal
proteins and other translator proteins. The first category
encompasses genes directly involved in energy gener-
ation, including the ATP synthase subunits, cytochrome
C encoding genes and NADH dehydrogenase genes.
This correlates very well with the recent findings by Lien
et al. [33] on metabolome changes in P. fluorescens
SBW25, where it is shown that the most significant
metabolome changes are changes in the GXP pool re-
lated to alginate synthesis and changes in the AXP pool
related to mucA inactivation. The second notable set of
upregulated genes encode functions on both sides of the
succinate node in the TCA cycle, i.e. the succinate de-
hydrogenase and succinyl-CoA synthetase complexes. In
this context, it is noteworthy that succinate dehydrogen-
ase is the only enzyme that catalyzes reactions in both
the TCA cycle and the electron transport chain. Other
metabolic genes upregulated above the 2-fold thresholdin the mucA strain include the purine pathway genes
purF, purN; carbonic anhydrase; isocitrate dehydrogen-
ase; S-adenosylmethionine synthetase; PEP synthase and
both isoenzymes of glucose-6-phosphate dehydrogenase.
The genes PFLU3193–PFLU3201 display a remarkable
expression profile that is unique in the transcriptome data,
where the mucA inactivation seems to have opposite effect
depending on the carbon source. As these genes have
the same direction on the chromosome and very short
intergenic linkers, it seems probable that they are
co-transcribed. The genes upstream and downstream,
PFLU3192 and PFLU3202, do not share the same expres-
sion profile. Normalized gene expression profiles for the
first gene in the putative operon is shown in Figure 2; the
downstream genes show very similar expression profiles
(data not shown), supporting the assignment of these
genes to an operon structure. The expression level is
upregulated approximately twofold on fructose compared
to the wild-type, in the alginate producing mucA strain,
whereas this ratio is inverted in the glycerol-grown cul-
tures. Absolute expression values in the two cases also
vary approx. twofold between carbon source conditions
for the alginate producing strain, indicating that expres-
sion of these genes is regulated in a multifactorial way. All
of the genes in this putative operon are indicated by
BLAST sequence similarity to encode metabolic enzymes;
PFLU3193 shows high similarity to 2-ketoacid dehydro-
genase subunits, more specifically to pyruvate dehydro-
genase subunit E1. For the remaining genes in the cluster,
the exact reaction catalyzed is less clear, although there is
a strong indication of an involvement in fatty acid biosyn-
thesis or metabolism, as encoded by the presence of 3-
ketoacyl-acyl carrier protein (ACP) synthases (PFLU3201
and PFLU3199), ACP (PFLU3200), acyl-CoA oxidase
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natively, these enzymatic activities could participate in bio-
synthesis of polyketides; other strains of P. fluorescens are
known to produce such compounds, including mupirocin
[34], 4-diacetylphloroglucinol [35] and pyoluterin [36]. In
such a context, it is also interesting to note that for all the
genes PFLU3196–PFLU3201, the BLAST hits with the
highest similarity originate from members of the Strepto-
myces genus, known for their extensive polyketide biosyn-
thetic capabilities.
Genome-scale metabolic modelling
Metabolic reconstruction at the genome level
Reconstruction of an organism's complete metabolic
network comprises the assignment of well-defined bio-
chemical reactions to gene products, and the integration
of these reactions into a set that allows for simulation of
cellular growth, i.e. the conversion of growth substrates
into biomass and by-products (e.g. CO2), and potentially
the production of secondary metabolites like biopoly-
mers. The stoichiometry and completeness of the reac-
tion network is then validated by comparison of the
simulated results with wet-lab experiments. It is worth
noting that most genome-scale reconstructions up to
date make the simplifying assumption that growth occur
under steady-state conditions, so that the simulation can
be run as purely stoichiometric on an elemental basis
without time-dependent changes. Also, the effect of
regulation, which is critical to any organism's adaptation
to its environment, is usually ignored in the steady-state
assumption, although some work is beginning to appear
that integrates data on regulation with the metabolic
network structure [37].
The manual reconstruction of a metabolic network con-
tinues to be a labour-intensive process that is mainly
based on incorporation of knowledge published previously
on the organism in question. Since the first genome-scale
reconstructions were completed, the use of software and
databases for aid in this process has gathered significant
and increasing attention. Although the essential data is
mostly interconvertible between the different model for-
mats, the choice of reconstruction software will have some
influence on the exact model building strategy, format and
workflow. An attempt to automate the reconstruction
process for bacteria is the SEED database [38], which
maps genes through a web interface to a pre-constructed
metabolic network, generating a draft model in SBML for-
mat that can in principle be used directly for simulations.
Another software package for model reconstruction is the
Pathway Tools suite [39,40], which is built around
the BioCyc database collection of metabolic pathways
encompassing virtually all domains of life; currently, 1129
genomes and their respective databases are contained in
BioCyc. The comprehensiveness and degree of manualdatabase curation, as well as the fact that Pathway Tools is
still in active development almost a decade after it was
launched, contributed strongly to the decision of making
it a central tool in this work.
A more recent development in the quest for (semi-)
automation of the reconstruction process is the RAVEN
Toolbox software suite [Agren et al., submitted] [41] that
integrates both the reconstruction and subsequent flux
simulations on the model. One significant advantage of
the latter approach is the complete control that the user
exerts on every sub-step of the model construction; the
reconstructed network and the input parameters for simu-
lation all reside in a spreadsheet format that constitutes a
detailed, intuitive and easily accessible overview of all re-
actions, metabolites, genes and simulation parameters.
Here, a hybrid approach was pursued, combining the
proven reconstruction power of the Pathway Tools soft-
ware with the user accessibility and simulation power
of the RAVEN Toolbox. Based on the annotated P.
fluorescens SBW25 genome [21] we used Pathway Tools
v12.0 to reconstruct a draft metabolic model, as described
in Materials and Methods. As the model reconstructed in
Pathway Tools was not formulated or formatted for simu-
lation purposes, the model was restructured into RAVEN
Toolbox format.
The final model contains 1194 metabolites participat-
ing in 1012 unique biochemical reactions, of which 126
are transport reactions. 1139 ORFs are associated to the
reactions, and 367 of the proteins encoded participate in
112 protein complexes. The model is denoted iSB1139
by nomenclature convention [42], and the distribution
of reactions in functional classes is shown in Figure 3.
Comparison between Pseudomonas genome-scale models
Genome-scale metabolic reconstructions of bacteria are
conceptually similar, the differences being mainly the se-
lection and number of entities (genes, reactions, metabo-
lites) included in each reconstruction. We performed a
reaction-by-reaction manual comparison of the three
Pseudomonas genome-scale models considered here,
iJN746 (P. putida KT2440) [25], iMO1056 (P. aeruginosa
PAO1) [23] and iSB1139 (P. fluorescens SBW25, this
work). The complete comparison in tabular format can be
found in Additional file 3. Reactions in the P. putida
model describing diffusion from periplasm to extracellular
space were excluded, as were so-called exchange reactions
in both the P. putida and P. fluorescens models. Such ex-
change reactions are added to facilitate flux simulations,
but do not represent cellular processes. The complement
of shared and unique reactions between the three Pseudo-
monas models is visualized as a Venn diagram in Figure 4.
All three models have a shared core inventory of 482 reac-
tions. The alginate biosynthetic genes, of special interest
here, are conserved in the P. aeruginosa and P. fluorescens
Amino acid
Fatty acid
Nucleotid
Central met. / Energy
Sulfur
Urea / nitrogen
Vitamin, cofactor, steroid
Porphyrin
Cell envelope
Transport
Alternate carbon
Alginate Other
Figure 3 Reaction classes present in the iSB1139 metabolic
network. Classification and distribution of all reactions in the
iSB1139 genome-scale metabolic model of P. fluorescens SBW25
into functional groups of the overall metabolic network.
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though the genes are present in the organism.
Among reactions unique to the iMO1056model of P.
aeruginosa, two functional groups stand out in numbers;
the first group is transport (46 reactions) with unique sub-
strates or unique transport mechanisms on common sub-
strates. The second group constitutes biosynthesis of
virulence factors (44 reactions), including LPS/lipid AFigure 4 Metabolic reaction overlap and uniqueness in
published Pseudomonas models. Venn diagram of reactions
present in the iMO1056 (P. aeruginosa PAO1), iJN746 (P. putida
KT2440) and iSB1139 (P. fluorescens SBW25) genome-scale metabolic
models discussed here.biosynthesis, quorum sensing biosynthetic pathways
and phenazine biosynthesis, reflecting the pathogenic
lifestyle of P. aeruginosa and its emphasis in the model-
ing process.
For the iJN746 P. putida model, degradation of aro-
matic compounds, including the beta-ketoadipate path-
way, constitutes 56 reactions unique to this model,
whereas the biosynthetic pathway for the industrially
relevant polymer polyhydroxyalkanoate (PHA) contains
26 unique reactions. The existence of an alternative, 12-
step lysine degradation pathway in P. putida, as de-
scribed by Revelles et al. [43] is also noteworthy in the
comparison of metabolic capabilities contained in the
three models, as this pathway has been suggested [44] to
replenish TCA cycle intermediates.
In the P. fluorescens model, unique reactions encom-
pass a significant number concerning transport (33 reac-
tions). Metabolism of alternate carbon compounds,
either as complete pathways (e.g. metabolism of 4-
hydroxyphenyl acetate) or as smaller sets of reactions,
constitute a significant fraction of these unique reac-
tions; some are introduced by the reconstruction soft-
ware without being well connected to the metabolic
network. They are, however, retained in the model so it
can serve as a knowledge base for the organism and also
for the future potential integration in the main meta-
bolic network as improved annotation of metabolic
genes becomes available. These detached reactions are
not detrimental to the flux simulations as they are ex-
cluded from the working SBML model.
When assessing model completeness, 27 reactions are
found to be part of both the P. aeruginosa and P. putida
model, but not included in the P. fluorescens model de-
scribed here. All of these, however, represent reactions
with dead-end metabolites, reactions with alternative co-
factors, transport reactions or reactions already de-
scribed (above) as absent from the P. fluorescens SBW25
model. Thus, no significant metabolic 'holes' exist solely
in the P. fluorescens model. Comparison of manually
constructed genome-scale models is challenging, in that
the reconstruction process involves a significant number
of non-standardized decisions, notably in the association
of metabolic reaction substrates, products and cofactors
to genes and gene products. Oberhardt et al. [45] have
very recently developed an elaborate process for recon-
ciliation of genome-scale metabolic models, and demon-
strated its application on the previously published
models of P. aeruginosa PAO1 and P. putida KT2440.
Although the described process was based on a manual
reconciliation of the two models, the authors suggest a
workflow that should be amenable to a degree of auto-
mation and might provide a first step on the path to-
wards full multi-model comparisons on a metabolic
network level.
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parameters in the iSB1139 model
Biomass composition in the iSB1139 model was chosen
to be identical to that used for the P. putida iJN746
model [25], in turn based very closely on measured
values for E. coli [46,47]. For the second P. putida
KT2440 model iJP815 [24], simulations indicated that
using the experimentally verified biomass composition
for E. coli, in the absence of experimental data for P.
putida, was a sound approximation. Furthermore, Roels
[48] found very similar elemental composition and ash
content for P. fluorescens and E. coli under unlimited
growth. The growth associated ATP consumption that
we have used is an average between the values for P.
putida and P. aeruginosa (both closely based on the
value from E. coli), which is equal to 43 mmol of ATP
per gram of biomass produced.
The annotated genome of P. fluorescens SBW25 indi-
cated the presence in the electron transport chain of at
least three terminal oxidases, cytochrome c oxidase, bd
(ubiquinol) oxidase and bo (ubiquinol) oxidase, with dif-
ferent ATP-generating efficiencies. Such complementary
systems are thought to be optimized for cellular energy
generation under different dissolved oxygen tension in
the cytoplasm [49,50].
While cytochrome c oxidase translocates 6 protons for
each pair of electrons transferred to oxygen, bd and bo
translocate only 2 protons. The overall theoretical P/O
ratio (in absence of proton leakages across the mem-
brane) can therefore vary between 2.5 and 1.5 depending
on which terminal oxidase is active.
Theoretical and experimental biomass yields
The strains not producing alginate show different biomass
yields on fructose (see Table 1). The wild type strain and
the ΔalgC mutant have biomass yields of 0.14 g-DW/g-
fructose, while the double mutants mucA ΔalgC and
mucA TTalgD show yields of 0.23 and 0.24 g-DW/g-fruc-
tose, respectively. As calculated from the model, the opti-
mal biomass yields in fructose using P/O ratios of 2.5 and
1.5, respectively, are 0.72 and 0.58 g-DW/g-fructose. A
typical bacterial non-growth associated ATP consumption
of 1.5 mmol-ATP per g-DW per hour [51] would explain
only a further drop of 0.06 g-DW/g-fructose. This means
that the experimental biomass yield is far from optimal
and the cells are using inefficient biomass synthesis path-
ways or are dissipating energy in futile cycles. In the next
section it will be shown that the difference in biomass
yield between the wild type strain and the ΔalgC mutant
with respect to the mucA ΔalgC and mucA TTalgD mu-
tants can be explained by the activity of a cycle oxidizing
NADPH without ATP production, which is consistent
with a suboptimal metabolism in terms of energy
utilization. This lack of optimality could be due to thedifference in growth conditions between the chemostat
situation (40 g/l of fructose or glycerol) and the native soil
habitat of P. fluorescens, e.g. that the chemostat condition
is one of relative carbon excess for which the metabolic
network is not evolved optimally.
The same lack of optimality in the biomass yield can
be observed when the cells grow using glycerol as a car-
bon source. The wild type and the mucA TTalgD strains
show biomass yields of 0.16 and 0.20 g-DW/g-glycerol,
while the optimal yields for P/O ratios of 2.5 and 1.5 re-
spectively are 0.81 and 0.65 g-DW/g-glycerol.
Theoretical and experimental alginate yields
In order to calculate the actual efficiency of alginate bio-
synthesis of the alginate producing mucA strain we have
subtracted from the carbon source consumed the
amount of carbon that is dedicated to biomass produc-
tion in the non-alginate-producing strain with the
highest biomass yield, i.e. the maximum amount of car-
bon P. fluorescens SBW25 can channel into biomass
under any of the conditions tested here. Alginate yields
calculated on the remaining carbon available will then
be relative to carbon used for alginate biosynthesis. The
resulting efficiencies of alginate biosynthesis are 0.99
mmol-alginate/mmol-fructose and 0.5 mmol-alginate
/mmol-glycerol. The theoretical yields on fructose using
P/O ratios of 2.5 and 1.5 respectively are 0.93 and 0.85
mmol-alginate/mmol-fructose, which means that under
the above approximation of an upper threshold of bio-
mass yield, the alginate biosynthesis is operating close to
its optimal stoichiometric yield. The alginate biosyn-
thesis from glycerol does not require the oxidative phos-
phorylation and has a theoretical yield of 0.45 mmol-
alginate/mmol-glycerol, which is independent of the P/O
ratio chosen, this is due to the fact that, when glycerol is
supplied as the carbon source, the metabolic network is
flexible enough to compensate the difference in respira-
tory ATP yield by using the reaction catalyzed by pyru-
vate kinase as an alternative ATP source. The results
seem to indicate that the cell is able to transform both car-
bon sources into alginate in a close to optimal way even if
their biomass production is far from optimal. Indeed, the
fraction of imported carbon that goes into alginate is very
high; 71% and 68% on fructose and glycerol, respectively.
All the above would indicate that in order to use the
mucA strain as an optimal alginate-producing cell factory
it could be enough to use it in non-growing conditions
such as for example under nitrogen deprivation.
Random sampling
The functional association of the measured transcrip-
tome data to actual metabolic fluxes is challenging, as it
has been shown that there is no clear correlation be-
tween gene expression and protein concentration [52] or
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vex basis random sampling’ method [55], which allows
for a genome-scale statistical comparison of experimen-
tal gene expression changes and estimated metabolic
fluxes. The advantage of this method is that it uses the
observed changes (between two conditions) in a small
set of experimentally measured fluxes such as respir-
ation, carbon source uptake rate, secondary metabolite
production etc. to infer the probabilities of flux change
in each of the fluxes in the genome-scale metabolic net-
work. This method facilitates the classification of en-
zymes as either transcriptionally regulated (i.e. showing
significant correlation between flux change and gene ex-
pression change), metabolically regulated if change in
the corresponding reaction is likely to be driven only by
metabolite concentrations or post-transcriptionally regu-
lated (i.e. where a significant expression change does not
correlate with the estimated flux change). Each reaction
in the network is assigned a score between 0 and 1,
which indicates the likelihood for the reaction to be
transcriptionally regulated. The reactions can be sorted
by their corresponding scores in order to identify which
transcriptional changes have a greater impact on the ob-
served changes in the metabolic phenotype.
Here this method was applied to the genome-scale re-
construction of P. fluorescens SBW25. The experimental
conditions for comparison in this case were the strain–
carbon source combinations, whereas the measured vari-
ables were the microarray data sets and observed ex-
change fluxes in the chemostat cultivations, i.e. carbon
source consumption and production of CO2 (respir-
ation), alginate (including acetylation), and cell biomass.
Note that specific growth rate was fixed at 0.04 hr-1 for
all cultivations. Pairwise comparisons were done of the
wild-type strain vs. all mutants on each carbon source.
Wild type versus mucA strain on fructose
In the alginate-producing mucA strain growing on fruc-
tose, unsurprisingly, the reactions involved in the alginate
biosynthetic pathway, encoded by algD, algG, algX, algI,
algJ, algF, algA and algC, appeared to be transcriptionally
up-regulated with high evidence scores. The reaction PEP
synthase (generating PEP for the fructose PTS transport
system), which is associated in the model with the gene
PFLU4620, shows a strong transcriptional up-regulation
(with the 8th top ranking evidence score). This reaction is
coupled to fructose transport and phosphorylation, which
is consistent with the much higher specific fructose uptake
rate in mucA compared with the wild type. The gene asso-
ciation that appears in the model is uncertain and the
gene PFLU4620 is annotated as a putative PEP synthase.
The fact that the flux in the reaction PEP synthase appears
to be well correlated with the change in the transcription
level of PFLU4620 indicates the gene association.Interestingly, a highly significant transcriptional down-
regulation of ribose-5-phosphate isomerase A (RpiA) is
also found (with the 4th ranking evidence score). This
enzyme is central in the pentose phosphate pathway. A
down regulation of this pathway would mean that the
cells produce less NADPH and more NADH.
The amount of energy required for alginate biosynthesis
is significant; per mole of extracellular fructose incorpo-
rated in (extracellular) alginate, three moles of high-energy
phosphate esters (PEP, ATP and GTP) are hydrolyzed,
and two moles of NAD+ are reduced to NADH. From the
random sampling analysis, pyruvate dehydrogenase cyto-
chrome (PoxB), ubiquinol-cytochrome C reductase and
cytochrome C oxidase appear as transcriptionally up-
regulated reactions (6th, 9th and 10th evidence scores). The
F0F1 ATP synthase appears ranked in the 15th position by
evidence score. These alterations would support an in-
creased ATP production rate in order to supply the neces-
sary energy for alginate biosynthesis. As shown by Lien
et al. [33], the most significant changes in the metabolome
of SBW25 are alterations in the GXP and AXP pools upon
biosynthesis of alginate and mucA inactivation, respectively.
This is in good correlation with the results from the ran-
dom sampling analysis.
Wild type versus ΔalgC mutant in fructose
Comparison of the ΔalgC mutant with the wild-type
yielded only very small phenotypical changes and it was
therefore not possible to detect any significantly
perturbed fluxes using the random sampling algorithm.
Wild type versus the double mutants mucA ΔalgC and
mucA TTalgD in fructose
For the double mutants mucA ΔalgC and mucA TTalgD,
an interesting pattern occurs; the three highest ranked
reactions identified as showing transcriptional regulation
of their fluxes in the mucA ΔalgC strain (all down-
regulated) form an NADPH oxidizing cycle together
with the 9th ranked reaction (also down-regulated), with
the overall net stoichiometry NADPH +H+ + ½ O2→
H2O +NADP
+. The reactions underlying this cycle are:
(1) Aspartate aminotransferase (AatB; PFLU3176): L-
glutamate + oxaloacetate→ L-aspartate + alpha-
ketoglutarate
(2) Catalase (KatB; PFLU5339): H2O2→H2O +½ O2
(3)NADP-specific glutamate dehydrogenase (GdhA;
PFLU5326) : NADPH + alpha-ketoglutarate +
NH4
+→ L-glutamate + NADP+ + H2O
(4) L-aspartate oxidase (NadB; PFLU1465): L-aspartate
+ O2 + H3O
+→NH4
+ + H2O2 + oxaloacetate
Strikingly, down-regulation of three of the above four
reactions, specifically (2), (3) and (4) also rank within the
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cation that the same metabolic mechanism is function-
ing in this strain too.
Cyclic operation of pathways in central metabolism is
widespread in bacteria [56], although such pathways rarely
imply a direct dissipation of energy or cellular reductive
potential, as suggested for the cycle (1)–(4). There are, how-
ever, examples both in bacteria [57,58] and yeast [59] where
overproduction of NADPH, primarily from increased
flux through the pentose phosphate pathway, causes a
metabolic imbalance that must be corrected by reoxidation
of NADPH without concomitant anabolism. Soluble
transhydrogenases, like UdhA in E. coli [60], are considered
important for NAPDH balancing in some species through
the equilibrium NADPH+NAD+ ↔ NADP+ + NADH.
However, as udhA analogs are only found in Enterobacteria,
other mechanisms for NADPH reoxidation must exist.
Fuhrer and Sauer [61] investigated growth and NADPH
balancing in eight bacterial species, including P. fluorescens
strain 52–1C, on glucose. They found that for six of these
species, NADPH biosynthesis exceeded anabolic demands,
and four of these six species relied on other redox-
balancing systems than transhydrogenase reactions. Such
systems were suggested to include dual cofactor specificities
of catabolic enzymes or isoenzymes with distinctive cofac-
tor specificities, as well as the possible existence of redox
cycles and NADH kinases. In the P. fluorescens strain,
NADPH biosynthesis seemed balanced under glucose
growth, and the absence of soluble transhydrogenase activ-
ity was experimentally verified. Interestingly, Chavarría
et al. [62] very recently demonstrated regulation of the
pyruvate shunt (malate – pyruvate – oxaloacetate) in P.
putida KT2440 by the PtsN paralog of the FruB fructose-
specific PTS protein. When PtsN was inactivated, either by
gene knock-out or by mutagenesis of the phosphorylation
site, the flux through the pyruvate shunt was increased
when either glucose or fructose was used as carbon source.
Moreover, flux through the shunt was 2.4-fold higher on
fructose (a PTS substrate) than on glucose (a non-PTS sub-
strate). This is of relevance for the results reported here
since the pyruvate shunt constitutes a seemingly futile by-
pass of one reaction in the TCA cycle, as ATP is hydrolyzed
in the shunt. All the relevant genes described in the
P. putida case (ptsP, ptsO, ptsN) are present (and virtually
identical at the amino acid level) in P. fluorescens SBW25,
strongly suggesting that similar mechanisms will be at
play in the latter strain and thereby implying the condi-
tional use of futile reactions in central metabolism as regu-
latory mechanisms.
For both the mucA ΔalgC and mucA TTalgD strains,
the rpiA encoded ribose-5-phopshate isomerase A
(PFLU5824) appears transcriptionally down-regulated
compared to the wild type, with evidence scores ranking
4th and 10th in the two former strains, respectively. Assuggested for the mucA strain, this could represent a re-
duced activity of the pentose phosphate pathway. For
the wild-type and the ΔalgC strains, the cycle (1)–(4)
could re-oxidise surplus NADPH generated by the
higher flux through the pentose phosphate pathway, ef-
fectively generating a cycle dissipating reductive poten-
tial. Phenotypically, this would then translate into lower
biomass yield, observable as higher relative respiration
for the wild-type and the ΔalgC strains (see Table 2).
Wild type versus mucA TTalgD in glycerol
When glycerol is used as a carbon source, the random
sampling algorithm could not identify any significant tran-
scriptionally regulated fluxes in the alginate non-producing
mucATTalgD mutant relative to the wild type.
It is noteworthy that the reactions constituting the
NADPH consuming cycle suggested above for two of
the fructose-grown strains do not come out as signifi-
cantly transcriptionally regulated in the wild type–mucA
TTalgD comparison on glycerol. The genes aatB and
katB showed a down-regulation in the mucA TTalgD
with respect to the wild type that is as strong during
growth on glycerol as on fructose; however the men-
tioned down-regulation does not seem to have any im-
pact in the metabolic fluxes when glycerol is the carbon
source, as the mentioned cycle is only modeled as active
when the cells grow on fructose. This is in agreement
with observed differences in respiration; if ratios of res-
piration per dry weight is calculated (from the values in
Table 2) for the wild type relative to the mucA TTalgD
mutant, this ratio is significantly higher when fructose is
used as a carbon source (wild type = 7.5 mmolC/g-DW
hr; mutant = 3.9 mmolC/g-DW hr; ratio = 1.92) than
when glycerol is used (wild type = 6.4 mmolC/g-DW hr;
mutant = 5.0 mmolC/g-DW hr; ratio = 1.28). Both in
relative and absolute terms, the change in respiration as
a function of the mucA inactivation is clearly more pro-
found on fructose than on glycerol again supporting the
hypothesis of an NADPH oxidizing cycle in operation
when the wild type cells are growing on fructose.
Wild type versus mucA in glycerol
When the wild type and the mucA strains were grown
with glycerol as the sole carbon source five proteins
encoded by genes from the alginate biosynthetic operon
are ranked 1st to 5th in the list of transcriptionally regu-
lated enzymes, which is similar to the observations for
this strain on fructose. Within the 6th to 10th ranking
enzymes, two are directly involved in glycerol uptake
and conversion (fructose bisphosphate aldolase Fba
[PFLU5701] and the GlpF glycerol uptake facilitator pro-
tein [PFLU1143]), two contribute to energy generation
by oxidative phosphorylation (the Ndh NADH dehydro-
genase II [PFLU0783] and ATP synthase) and one (Ndk;
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GTP from ATP for consumption in alginate biosyn-
thesis. It thus seems that all the top ranking enzymes
suggested to be transcriptionally regulated can be linked
directly to the uptake and conversion of the carbon
source into alginate when the organism is grown on gly-
cerol. This is in contrast to the situation on fructose as
described above, and it could indicate that although only
a few biochemical steps are different between the path-
ways leading to alginate from fructose and glycerol,
respectively, the organism seems to regulate the metab-
olism surrounding the alginate biosynthetic precursors
and cofactors quite differently on the two carbon
sources. This could be of relevance if metabolic engin-
eering of the alginate biosynthesis were to be pursued.
Conclusions
We have described the reconstruction and application of
a P. fluorescens SBW25 genome-scale metabolic model.
Genetic engineering was used to construct selected
strains with alterations in both the anti-sigma factor
mucA and alginate-specific genes, and the physiological
response was characterized by chemostat cultivations
and transcriptome analysis. Integration of the metabolic
model with the experimental data allowed us to obtain
new insight about the metabolism of this producer of
the commercially interesting biopolymer alginate. Firstly,
we could show that the yields of alginate are close to the
theoretical stoichiometric optimum, demonstrating the
very high efficiency of the alginate biosynthetic machin-
ery in this organism. We could also, however, see that
the biomass production of P. fluorescens SBW25 is
markedly suboptimal in the wild-type strain, and by the
use of random sampling analysis in the transcriptome
data set we could give strong indications that this
suboptimality on fructose is related to a cycle in the cen-
tral metabolism, effectively wasting cellular energy in the
form of NADPH. This cycle does not seem to be active
when the organism is grown on glycerol. The down-
regulation of the suspected NADPH oxidizing cycle was
observed in the mucA strains, adding to the putative
regulon of this global regulator.
The model described in this work, validated by compre-
hensive continuous-culture experimental data and inte-
grated with transcriptome analyses, nicely complements
the existing P. aeruginosa and P. putida models. Alginate
is a significant virulence factor in P. aeruginosa infections,
and the emphasis on alginate biosynthesis in the (non-
pathogenic) P. fluorescens system described here could
support the clinical research on this important pathogen.
Also, alginate is a valuable industrial product, and the
optimization of alginate production in bacterial systems is
of great commercial interest. As compared to the other
major alginate-producing bacterial genus, Azotobacter, therelative simplicity that applies to both engineering and
cultivating P. fluorescens – taken together with its highly
efficient alginate biosynthesis as described here – should
provide an argument for its applicability in an industrial
context. The heterologous expression of Azotobacter al-
ginate epimerases could then be used to produce high
yields of alginates with tailored monomer sequences.
Methods
Strain construction
The plasmids and strains used in this study are described in
Additional file 1. Plasmid isolations, enzymatic manipula-
tions of DNA, agarose gel electrophoresis and other routine
DNA manipulations were performed according to the
methods of Sambrook and Russell [63]. The QIAquick Gel
Extraction Kit and QIAquick PCR purification kit (Qiagen,
Germany) were used for DNA-purifications from agarose
gels and enzymatic reactions, respectively. PCR for cloning
and allele identification was performed using the Expand
High Fidelity PCR system (Roche Diagnostics, Switzerland).
DNA was sequenced using the Big-Dye Terminator v1.1
Cycle kit (Applied Biosystems, CA). Transformations of E.
coli were performed using the rubidium-chloride method
(available at www.neb.com). Matings and selection of double
recombinants were performed as described earlier [22,64].
Cultivation and sampling
Triplicate chemostat experiments were performed in 3
liter fermenters (Applikon, Netherlands) with a 0.75 liter
working volume and a feeding rate of 30 g/hr, corre-
sponding to a dilution rate, D = 0.04. Inoculation of
the chemostats was 3% from an overnight culture
grown in LB medium (all growth media are described in
Additional file 4), and the initial (batch phase) medium
in the fermenter was Def4m. Temperature was con-
trolled at 25°C, and pH was kept at 6.8 by addition of
NaOH. Aeration was 0.5 liters per liter culture volume,
and dissolved oxygen was controlled at 20% by adjusting
stirrer speed. Feeding was started after 24 hrs, and was
controlled on a weight basis. The chemostat feeding
growth medium, Def4, was fully defined with either fruc-
tose or glycerol (both 40 g/l) as the carbon source. Ex-
haust CO2 was measured continuously by online mass
spectrometry. Sampling was performed at steady state
for offline analysis of remaining carbon source, alginate
and transcriptome. Detailed sampling protocols can be
found in Additional file 4. During the cultivations bio-
mass was measured as OD660 and this was converted to
biomass concentration in gDW/L using a conversion of
0.36 g/L OD unit.
Carbon source, alginate and transcriptome analysis
Remaining carbon source in the chemostat growth
medium was analyzed by HPLC on a 300x7.8 mm
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45°C with 0.6 ml/min of 5 mM H2SO4 as the mobile
phase. Alginate in the medium was quantified as de-
scribed previously [11]. Since the alginate quantification
assay operates on deacetylated alginate, acetylation had
to be determined separately. This was done with the
same anion exchange HPLC method that was used for
quantification of residual carbon source. The acidic buf-
fer used is sufficient to deacetylate alginate, so acetate
can be measured directly.
Transcriptome analysis was done on a custom 385K
60-mer expression microarray (Roche NimbleGen Inc.,
WI) covering the P. fluorescens SBW25 genome. RNA
was isolated with the RNEasy Midi Kit (Qiagen), and
when necessary was up-concentrated with Microcon YM
30 spin columns (Millipore, MA). cDNA was produced
from isolated RNA according to Roche NimbleGen Inc.
instructions, from which hybridization and array scan-
ning was purchased as a service. Analysis of the micro-
array data was done with GeneSpring GX software,
version 11 (Agilent, CA).
Metabolic network reconstruction and analysis
Reconstruction of the draft metabolic network in P.
fluorescens SBW25 was based on the recently published
annotated genome of the organism [21], and was done
in a semi-automated fashion by using the Pathway Tools
software suite [39], including the HoleFiller algorithm
for closing gaps in the metabolic network. During the
first phase of the reconstruction, the software automatic-
ally connects the gene products and reactions that can
be unambiguously established from the genome annota-
tion and sequence when compared to the existing inven-
tory of genome/pathway databases. For enzyme–
reactions associations that have a higher degree of un-
certainty, the user is presented with the reactions that
are hypothesized to be present in the network and po-
tential enzymes (or, more accurately, their encoding
genes) that could catalyse the reaction in question. The
accurate assignment is then made based on manual cur-
ation. After this curation process is completed, an algo-
rithm is called that identifies 'holes' in the metabolic
network. A metabolic hole is a single biochemical reac-
tion that is absent from an otherwise complete pathway,
in such a way that filling of the hole yields a functional
pathway that can carry a metabolic flux. If candidate
gene products for filling the metabolic holes can be
identified by the software, these are presented to the
user for manual curation. This hole-filling is an iterative
process, since introduction of new reactions into the
network might justify the introduction of yet new path-
ways in the model, depending on the manually set cut-
off for presence of a given pathway in the model. In the
case of the draft model of P. fluorescens SBW25, themanual curation constituted verification of 90 enzyme–
reaction connections and assignment of 43 protein com-
plexes. 92 'holes' in the metabolic network were filled by
manual curation, distributed as 74, 16 and 2 in the first,
second and third iterations of the algorithm, respect-
ively. Manual curation of the draft model was done by
literature studies and use of online databases. Literature
references used in the manual curation of the draft
model are listed in Additional file 5.
The draft model was translated into the RAVEN Tool-
box format [Agren et al., submitted; for overview see [41]]
by the use of custom Perl scripts. Concomitantly, a further
manual pruning of the model was performed. This in-
cluded the removal of non-metabolic reactions and reac-
tions with generalized substrates, dereplication of
reactions performed by isoenzymes and alternative formu-
lations of reactions as found in Pathway Tools, assignment
of reaction irreversibility where applicable and verification
of cofactor specificities. Furthermore, sequence and net-
work comparison with the iJN746 and iMO1056 models
for P. putida KT2440 and P. aeruginosa PAO1, respect-
ively, allowed for addition of 38 reactions. Also, the path-
ways in the P. fluorescens SBW25 model defining fatty
acid biosynthesis, glycerophospholipid metabolism and
peptidoglycan biosynthesis were incomplete in the Path-
way Tools formulation, and was manually completed by
comparison with the iJN746 model as highly homologous
gene products could be found for all reactions.
The final model was designated iSB1139. The model is
available for download in both Excel format and in
SBML at www.sysbio.se/biomet. Flux balance analysis of
the SBW25 model was performed with the linear pro-
gramming solver Mosek (Mosek ApS, Denmark) for
Matlab (The Mathworks, MA).
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Additional file 3: A spreadsheet comparison and alignment of the
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Additional file 5: The literature references used in the manual
curation of the draft genome-scale metabolic model.
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